Karisalai ennai (Internal) and Aavaraiver ennai (External) in the management of Karappan (Eczema) in childre
Phase 2
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2020/06/026084
- Lead Sponsor
- Ayothidoss pandithar hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children of both sexes in the age group of 7 to 12 years with symptoms of:
ï??Erythema
ï??Edema
ï??Oozing
ï??Itching
ï??Crusting and scaling
ï??Lichentified plaque
ï??Willing to give Biological samples whenever necessary.
Exclusion Criteria
ï??Scabies
ï??Photodermatitis
ï??Fungal and parasitic skin infection
ï??Psoriasis
ï??Any other serious illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of the trial drug is measured by using EASI SCORE and Improvement in the clinical condition will be observed. <br/ ><br> <br/ ><br>Timepoint: 12 months
- Secondary Outcome Measures
Name Time Method Reduction in the recurrence of the disease and improvement in the quality of life of children. <br/ ><br> <br/ ><br>Timepoint: 12 months